NCT03328611 is a clinical trial of Hip and Knee Joint Replacement in Joint Replacement, sponsored by Midwest Center for Joint Replacement.

Who is sponsoring NCT03328611?

NCT03328611 is sponsored by Midwest Center for Joint Replacement.

What drugs are being tested in NCT03328611?

Interventions in NCT03328611: Hip and Knee Joint Replacement.

What condition does NCT03328611 study?

NCT03328611 studies Joint Replacement.

Is NCT03328611 still recruiting?

NCT03328611 is currently recruiting now. Last updated 2 September 2020.

Last reviewed 2020-09-02 · How we verify

NCT03328611

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MCJR Joint Replacement Clinical Outcomes Database

Recruiting now Last updated 2 September 2020

What this trial tests

trial testing Hip and Knee Joint Replacement in Joint Replacement in 2,000 participants. Currently enrolling.

Timeline

1 August 2021

Primary endpoint
31 December 2050

31 December 2050

Quick facts

Lead sponsor	Midwest Center for Joint Replacement
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	1 August 2021
Primary completion	31 December 2050
Estimated completion	31 December 2050
Sites	1 location across United States

Drugs / interventions tested

Hip and Knee Joint Replacement

Conditions studied

Joint Replacement — all drugs for Joint Replacement →

Sponsor

Midwest Center for Joint Replacement

Who can join

Eligibility, any sex, with Joint Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to develop a database of information regarding the diagnosis, treatment, and outcome of participants who have had a joint replacement. The more information gathered, the better the investigators will be able to treat future patients who need a joint replacement. For example the investigators learn what works well to help design implants and treatment protocols for the future. The investigators publish manuscripts and present research findings around the world to help other investigators and clinicians learn what is discovered. Furthermore, implant manufacturers may be able to use this information in the database to evaluate the success rates of specific joint replacement products.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03328611 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Midwest Center for Joint Replacement
Last refreshed: 2 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03328611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing